$1,000 in Tempus AI (TEM) One Year Ago? Here’s the Jaw-Dropping Result Today
Tempus AI just schooled the S&P 500—here's what early believers cashed in.
The AI Stock That Outran Wall Street
While hedge funds obsessed over megacaps, TEM quietly delivered triple-digit returns. The same $1,000 that would've bought you three shares of NVIDIA now buys bragging rights at every fintech happy hour.
Coding Its Way to the Top
No splashy IPO circus—just machine learning models that actually work. TEM's algorithms ate legacy healthcare data systems for breakfast, turning regulatory hurdles into stepping stones.
The Punchline
Turns out you didn't need that 'sure thing' crypto meme coin after all. Another win for the nerds—and another loss for the finance bros still waiting on their Dogecoin Lambo.
Image source: Getty Images.
Despite the ups and downs, shares are in the black
Consistent with many stocks when they debut on public markets, Tempus AI stock has demonstrated some volatility in its 14 months as a publicly held company. Shares began trading on June 14, 2024, at $40, but they quickly plunged 29% in their first week of trading.
Once the market got to know the company a little better, shares fared much better. After performing well in the first several weeks of 2025, Tempus AI stock hit a high-water mark and closed at $89.44 on Feb. 14, representing a 124% gain over its opening price.
Those who bought Tempus AI stock when it first became available have seen their investments grow 56% as of this writing, while investors who bought Tempus AI stock exactly one year ago -- Aug. 5, 2024 -- have seen their holding climb a slightly lower 51%. Those who invested $1,000 a year ago, now have a position valued at $1,510.
Is now a good time to load up on Tempus AI stock?
Because Tempus AI is unprofitable, traditional valuation metrics aren't useful in assessing the stock's price tag. However, its price-to-sales ratio of roughly 10 seems reasonable, considering its substantial market opportunity as it develops AI solutions to help physicians provide individualized patient care and assist researchers in discovering new pharmaceuticals.
